VLA
Click for more information
0.00% $1.75 viralytics limited

wish i was a medico, page-5

  1. milward
    89 Posts.
    lightbulb Created with Sketch. 12
    clock Created with Sketch.
    09/04/14
    12:51
    Post #: 13231529
    Amgen misses its survival goal in the melanoma phase 3 trial.
    Amgen said T-VEC hits its primary endpoint of durable response in patients with metastatic melanoma but missed its second goal of boosting overall survival.
    VLA Price at posting: 30.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Consumer Staples Shine Amid Retail Slump – Key Stocks to Watch
right-arrow Created with Sketch.
HVN Consumers cautious according to Harvey Norman, as profit slumps 35% in FY24
right-arrow Created with Sketch.
NEWS Week 35 Wrap: HotCopper’s top watched; ‘iron ore winter’ has started; Oz inflation @ 3.5% MoM; Harris fracking flip
right-arrow Created with Sketch.
NEWS Government spend has to stop or interest rates must rise, property expert
right-arrow Created with Sketch.
HAR Haranga Resources reports significant resource upgrade at Saraya Uranium Project
right-arrow Created with Sketch.
NEWS Results wrap: Wesfarmers, Southern Cross Media, Qantas
right-arrow Created with Sketch.
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.